.jpg)
To achieve sustainable growth and enhance medium-term corporate value, we aim to maintain a properly developed corporate governance system and are working toward building an optimal governance structure.
In the area of compliance, each officer and employee is committed to acting in accordance with the “Compliance Action Guidelines” to realize our corporate philosophy, and we are strengthening the compliance promotion structure across the entire group, including overseas operations.
At Takara Bio, we have established a “Compliance Committee” chaired by the President to strengthen the compliance promotion structure across the entire group.
In addition, the Takara Group has established the “Takara Group Compliance Action Guidelines.” By ensuring that all group companies comply with laws and social ethics and properly manage risks, we aim to prevent serious compliance violations, including corruption. Through these efforts, the entire group seeks to fulfill its corporate social responsibility and enhance corporate value.
The Takara Group aims to realize its corporate philosophy; "Contributing to the creation of a vital society and a healthy lifestyle through our fermentation and biotechnology, emphasizing harmony with nature."
In the process of realizing it, we perform business activities honestly and fairly under the Takara Five Values, which are the shared values of the Group.
(1) We will comply with laws and regulations in Japan and overseas, fully recognize social ethics, and act with common sense and responsibility as a member of society.
(2) We will work to lower environmental burdens, and contribute to the development of life science that values the dignity of life.
(3) We will conduct sustainable business activities that are widely useful to society by pursuing profit through fair competition rather than pursuing profit in a manner contrary to these Action Guidelines.
(4) We will comply with employment regulations, and will not engage in any unfair or dishonest practices in violation of employment regulations.
(5) We will always draw a line between public and private matters, and will not pursue personal gain by using corporate assets, information, business authority, or position.
In order to enhance employees’ compliance awareness, the Takara Group issues compliance newsletters on relevant and familiar topics and offers monthly e-learning courses. The Group also provides tiered training programs tailored to employee levels, including seminars for top management led by external experts, annual training for risk and compliance leaders responsible for promoting workplace compliance, as well as training for new managers and new employees.
We have established the “Takara Group Helpline” as a reporting channel for legal violations or misconduct. It includes both internal and external (third-party) contact points and is operated in accordance with whistleblower protection regulations to ensure that reporters are not subject to disadvantageous treatment. Reports received are investigated with strict confidentiality, and appropriate actions are taken based on confirmed facts.
In addition, our Group companies in overseas locations also have their local whistleblowing hotlines and have established and operate processes that allow their local employees to directly contact the helpline in Japan for reporting and consultation through a third-party organization.
Engaged in R&D business and contract business such as gene testing using human-derived tissue, cells, clinical materials, genome, gene, etc. and supply business of human tissue and cell products, Takara Bio complies with applicable laws and regulations and has established a bioethics committee to review ethical and safety aspects under appropriate oversight.
Takara Bio has established internal guidelines on animal experimentation and regulations governing the conduct of animal experiments in accordance with applicable laws, regulations, and guidelines. We strive to ensure that animal experiments are conducted rigorously and appropriately. Our animal experimentation facilities have been recognized for conducting scientifically appropriate animal experiments under a system of voluntary management and with due consideration for animal welfare. The facilities have been accredited by the Center for Accreditation of Laboratory Animal Care and Use of the Japan Pharmaceutical Information Center.
We promote the proper management and administration of public research funds based on “Guidelines for Management and Audit of Public Research Funds at Research Institutions” / “Guidelines for Responding to Misconduct in Research” by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and other relevant authorities.
For reporting matters related to the use and management of public research funds, please contact:
Takara Bio Inc.
Nojihigashi 7-4-38
Kusatsu, Shiga 525-0058 Japan
E-mail: bio-grant@takara-bio.co.jp
The Group conducts regular workplace inspections during normal operations to identify risks and implement countermeasures, and the results are discussed by the Compliance Committee. In addition, under its Business Continuity Planning (BCP) framework, the Group promotes initiatives to ensure the rapid recovery and continuation of operations in the event of major disruptions. In accordance with its basic policies and by leveraging its crisis management structure, the Group is prepared to respond to disasters, infectious disease outbreaks, supply chain disruptions, and other events that may significantly affect business activities.
As of April, 2026
